NEW YORK--(BUSINESS WIRE)--Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into Akebia Therapeutics, Inc. (NASDAQ:AKBA) (“Akebia”) related to potential violations of federal securities laws. If you are an Akebia shareholder, you are encouraged to contact Scott+Scott for additional information. Akebia (NASDA:AKBA) is a biopharmaceutical company that focuses on the development and commer
| < Prev | Next > |
|---|
